Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05477251
Other study ID # KY2021-263-B
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date October 1, 2022
Est. completion date December 31, 2026

Study information

Verified date August 2022
Source RenJi Hospital
Contact Jiachang Chi, Deputy chief physician
Phone 13761871073
Email chijiachang@aliyun.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

GGO is a characteristic focus of early lung cancer. Due to the abundant peripheral blood vessels and bronchial tissues around the GGO lesions located in pulmonary hilar, only lobectomy could be used for the surgical treat of hilar GGO lesions which will make the significantly decline of the pulmonary function after surgery and affect the quality of life to a great extent. Our previous study has reported a new blunt-tip MWA electrode (MTC-3CA-II3, Vison Medical Inc.) for the treatment of GGO lesions. The blunt-tip MWA electrode could improve the safety of GGO ablation, significantly reduce the occurrence of bleeding and hemoptysis, which made it possible to ablate GGO in the hilar region safely. In this study, the blunt-tip MWA electrode was used in the treatment of patients with hilar GGO lesions, and the efficacy and safety of microwave ablation and lobectomy in the treatment of ground glass nodules located in the pulmonary hilar region were evaluated and compared.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 100
Est. completion date December 31, 2026
Est. primary completion date December 31, 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: 1. The age ranged from 18 to 75 years old, male or female; 2. GGO lesions in the hilar region were diagnosed by imaging examination (CT / PET-CT). During the follow-up of 6-12 months, the lesions increased by more than 2mm, the solid components increased, or there were obvious solid components, or the GGOs were judged to be highly malignant by imaging. 3. The size of GGO lesions was 8mm-3cm, and the number of nodules was = 3. 4. There was no lymph node metastasis, intrapulmonary metastasis or distant organ metastasis; 5. After multidisciplinary evaluation, the patients were feasible for lobectomy and CT guided microwave treatment; 6. No bleeding tendency, normal coagulation function or coagulation dysfunction can be corrected after treatment; 7. Patients and /or family members agreed to join the clinical trial and signed informed consent. Exclusion Criteria: 1. The general condition of the patient is very poor, ECOG physical fitness score > 2, unable to tolerate lobectomy and MWA treatment, or has relevant contraindications; 2. The lesions had received other treatments before; patients with regional lymph node metastasis or distant metastasis or with pleural fluid and ascites; 3. Patients with poor compliance; 4. Severe heart, lung, kidney, brain and other important organ diseases; 5. The researcher believes that it is not suitable for inclusion

Study Design


Intervention

Procedure:
microwave ablation
MWA procedures were performed under local anesthesia and CT guidance (GE Discovery CT750 HD) was used for the guidance. Using the coaxial system, MWA was performed by the combining of a 17G sharp-tip guide trocar needle and a 15-cm cooled-shaft electrode (18-gauge) with a 1.5-cm expandable blunt-tip (MTC-3CA-II3, Vison Medical Inc.). Firstly, the sharp-tip guide trocar needle was used to puncture through the pleura and then the blunt-tip MWA electrode was advanced into the GGO lesion through the guide needle lumen. Once the target was reached, ablation was performed at a power of 40 watts. Once the lesion was covered by the ablation zone, the ablation completed.
lobectomy
lobectomy for GGOs located in hilar regions

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
RenJi Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary 3-year recurrence-free survival rate 3-year recurrence-free survival rate 3 year after treatment
Secondary Postoperative hospital stay Postoperative hospital stay During hospitalization
Secondary Total hospitalization expenses Total hospitalization expenses Total hospitalization expenses During hospitalization
Secondary Incidence of complications Incidence of complications Within 1 month after operation
See also
  Status Clinical Trial Phase
Completed NCT03649906 - A Clinical Study of Optimized CT-guided Pulmonary Nodule Microcoil Localization Technique N/A
Completed NCT05963945 - Multi-Reader Retrospective Study Examining Carebot AI CXR 2.0.21-v2.01 Implementation in Everyday Radiology Clinical Practice
Completed NCT04066699 - Percutaneous Localization: Open-label Registry of Thoracic Surgery
Completed NCT03591445 - Is Bronchoscopy Necessary in the Preoperative Workup of GGO Lung Cancer?(ECTOP-1005) N/A
Withdrawn NCT04894682 - Safety and Long-term Effects of COVID-19 Vaccines in Patients With Pulmonary Tumor
Recruiting NCT03790735 - The MDA Test to Differentiate of Benign and Malignant Pulmonary Nodules
Active, not recruiting NCT03992183 - Utility of CAML as Diagnostic for Early Stage Lung Cancer
Recruiting NCT04552054 - Mixed Reality Technique Combined With 3D Printing Navigational Template for Localizing Pulmonary Nodules N/A
Recruiting NCT05389774 - DOLCE: Determining the Impact of Optellum's Lung Cancer Prediction Solution
Recruiting NCT06308120 - A Trial to Compare Robotic Assisted Bronchoscopy Ion's Clinical Utility for Peripheral Lung Nodule Access and Diagnosis to ENB N/A
Completed NCT04209972 - The Benefit of UHR-CT: Precision of Repeated Volume Measurements of Pulmonary Nodules N/A
Completed NCT03181490 - Circulating Tumor DNA Methylation Test to Differentiate Benign and Malignant Pulmonary Nodules
Recruiting NCT05445635 - Added Value of a Small Camera (Iriscope) in the Endoscopic Diagnosis of Peripheral Lung Nodules and Masses N/A
Recruiting NCT04270799 - Lung Nodule Imaging Biobank for Radiomics and AI Research
Recruiting NCT00841750 - Chest Tube After a Video-assisted Thoracoscopic Surgery Pulmonary Wedge Resection Phase 3
Recruiting NCT06426628 - Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
Recruiting NCT05415670 - Benign/Malignant Pulmonary Nodule Classification Based on High-throughput Whole-genome Methylation Sequencing(GM-seq)
Recruiting NCT04005677 - The Early Diagnosis of Pulmonary Nodule Based on Multi-dimension Messages
Recruiting NCT05968898 - Assessment of a Radiomics-based Computer-Aided Diagnosis Tool for Pulmonary nodulES N/A
Completed NCT04302350 - Nitrous Oxide for Identifying the Intersegmental Plane in Segmentectomy: A Randomized Controlled Trial N/A